Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Teleconference: Who Will Win the Anti-Obesity Pill Race? (9:00 AM EST / 13:00 GMT)

Time & Location

Originally Presented: October 28, 2009 9:00 AM

Presenter(s):

GLG Expert Contributor

Agenda:

  • Reaction to Vivus Inc.’s Qnexa data Arena’s Lorcaserin data
  • Comparison of Qnexa, Contrave, Empatic, and Lorcaserin
  • FDA obesity drug approval guidelines and potential hurdles Vivus Inc., Orexigen Therapeutics and Arena may face
  • Impact of new oral drugs on obesity treatment regimens A transcript of this teleconference will be made available for purchase approximately 72 hours after the live call. To request a transcript, please click here.

Learn More About GLG Live Meetings

About GLG Live Meetings

A program focused on educating business and investment professionals through seminars on current trends and core concepts in various industries. Detailed workbooks distributed at the Seminars provide educational reference materials for later review. GLG Live Meetings enable clients to increase thier own industry education by proposing new seminar topics or adding agenda terms to currently scheduled seminars.